Two weeks after Amgen reported the top-line result of its CodeBreak-200 trial of Lumakras in lung cancer, the data has been presented in abstract form at ESMO, showing a 34% improvement in progression ...
According to a new report, Meta is aggressively working on a new pair of AR glasses that will have two displays. This is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback